SCHEMBL676019

SCHEMBL676019

CN(O)N=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210054028-A1 BACTERIAL SIDEROPHORE GRAMIBACTIN Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie - Hans-Knöll-Institut (DE) 2021-02-25 US disclosed
US-20160228460-A1 NITROXYL PROGENITORS IN THE TREATMENT OF HEART FAILURE NIH - DEITR 2016-08-11 US disclosed
US-9114071-B2 Oral pharmaceutical composition SIGMOID PHARMA LIMITED (IE) 2015-08-25 US disclosed
US-8980870-B2 Solid telmisartan pharmaceutical formulations BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-03-17 US disclosed
US-20150004259-A1 NITROXYL PROGENITORS IN THE TREATMENT OF HEART FAILURE NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2015-01-01 US disclosed
US-20130280855-A1 METHOD FOR PRODUCING COMPOUND HAVING CHALCOPYRITE STRUCTURE TOHOKU SEIKI INDUSTRIES, CO., LTD. (JP) 2013-10-24 US disclosed
US-8482504-B2 Liquid crystal display device and method of driving the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-07-09 US disclosed
US-20130138155-A1 Bone Regeneration Membrane and Method for Forming a Bone Regeneration Membrane CHU NANTES (FR) 2013-05-30 US disclosed
WO-2013058833-A1 COMPOSITIONS COMPRISING ALKALINE PHOSPHATASE AND/OR NATRIURETIC PEPTIDE AND METHODS OF USE THEREOF ENOBIA CANADA LIMITED PARTNERSHIP (CA) 2013-04-25 WO disclosed
EP-2032160-B2 VACCINE GLAXOSMITHKLINE BIOLOG SA (BE) 2013-04-03 EP disclosed
US-7799335-B2 Differential delivery of nitric oxide BOSTON SCIENTIFIC SCIMED, INC. (US) 2010-09-21 US disclosed
US-20090246296-A1 METHOD OF TREATING ISCHEMIA/REPERFUSION INJURY WITH NITROXYL DONORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2009-10-01 US disclosed
US-7425218-B2 Nitric oxide-releasing medical devices THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2008-09-16 US disclosed
US-7311858-B2 Barium, calcium, cadmium, magnesium, strontium, or zinc silicate doped with europium, and fluorine, iodine, chlorine, bromine, nitrogen, phosphorus, and/or sulfur; configured to absorb visible light from a blue light emitting diode (LED); white LEDs; YAG lasers INTEMATIX CORPORATION (US) 2007-12-25 US disclosed
US-7226586-B2 Highly cross-linked, extremely hydrophobic nitric oxide-releasing polymers and methods for their manufacture and use MEDTRONIC VASCULAR, INC. (US) 2007-06-05 US disclosed
US-20070087025-A1 Reiteratively layered medical devices and method of preparing same FITZHUGH ANTHONY 2007-04-19 US disclosed
US-20070059338-A1 Compositions and techniques for localized therapy KNAPP DAVID 2007-03-15 US disclosed
US-20070048297-A1 Human secreted proteins HUMAN GENOME SCIENCES, INC. (US) 2007-03-01 US disclosed
US-20070014828-A1 Cross-linked nitric oxide-releasing polyamine coated substrates, compositions comprising same and method of making same GOVERNMENT OF THE USA, REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) 2007-01-18 US disclosed
US-4144260-A Production of aluminum salts of N-nitroso-N-alkyl-hydroxylamines BASF AKTIENGESELLSCHAFT (DE) 1979-03-13 US disclosed